Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Galaxy Digital completes first tokenized collateralized loan note issuance, totaling $75 million

Galaxy Digital completes first tokenized collateralized loan note issuance, totaling $75 million

PANewsPANews2026/01/15 12:13
Show original

PANews reported on January 15 that Nasdaq-listed Galaxy Digital has announced the completion of its first tokenized collateralized loan obligation (CLO) on the Avalanche blockchain, named “Galaxy CLO 2025-1,” with a total size of $75 million. The related funds will be used to support Galaxy’s lending business, including financing an uncommitted credit facility provided to Arch Lending. It is reported that Galaxy’s lending team and digital infrastructure team were respectively responsible for the structuring and tokenization of this CLO, while Galaxy Asset Management is in charge of the issuance and management of the collateralized loan obligation.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

UBS is bullish on CoreWeave (CRWV.US): Initiates "Buy" rating, betting on the return of AI trading rotation.

UBS has initiated coverage of the emerging cloud service provider CoreWeave (CRWV.US) with a "Buy" rating and set a target price of $120.

智通财经2026/09/24 07:01

Sixth increase in six years! Disney(DIS.US) raises the monthly fee for Disney+ ad-free version by 13% to $21.49.

Walt Disney Company (DIS.US) is raising subscription prices for several of its streaming services in the U.S. market, marking the sixth price increase in six years, as the company aims to boost the profitability of its streaming business, which is crucial for Disney's future.

智通财经2026/09/24 06:51

Johnson & Johnson (JNJ.US) Tarlatamab to be included in China's priority review, aimed at inhibiting tumor formation and growth

On September 24, according to the CDE website, Johnson & Johnson’s (JNJ.US) talquetamab (Chinese brand name: Tuolike) is proposed to be included in priority review.

智通财经2026/09/24 06:51
Johnson & Johnson (JNJ.US) Tarlatamab to be included in China's priority review, aimed at inhibiting tumor formation and growth